MyCAA: Start your career today By: Kayla Nieves What does MyCAA stand for? Military Spouse Career Advancement Accounts 2 What is MyCAA? MyCAA is a “workforce development program" designed specifically for military spouses The SM must have a rank between E1 and E5, W1 and W2, and O1 and O2 Spouses married to service members in the Coasty Guard are not eligible Provides spouses who are eligible with up to ,000 in assistance Funds may only be used to licenses, certifications, and associate degrees MyCAA offers a fiscal cap for funds totaling

Mycaa Start Your Career Todayby Kayla Nieveswhat Does Mycaa Stand Fo

MyCAA: Start your career today By: Kayla Nieves What does MyCAA stand for? Military Spouse Career Advancement Accounts 2 What is MyCAA? MyCAA is a “workforce development program" designed specifically for military spouses The SM must have a rank between E1 and E5, W1 and W2, and O1 and O2 Spouses married to service members in the Coasty Guard are not eligible Provides spouses who are eligible with up to $4,000 in assistance Funds may only be used to licenses, certifications, and associate degrees MyCAA offers a fiscal cap for funds totaling $2,000 The Fiscal year begins in October Waivers can be offered if needed to increase this cap Purpose of MyCAA The purpose of MyCAA is to provide spouses with the opportunity to pursue an occupation or career field “Almost 43 percent of active duty members are 25 or younger and 23 percent range from 26 to 30 years old, according to the Department of Defense Demographics Report.

Over half (56.1 percent) on active duty are married.†Of these numbers, about 50% of those who are 25 are younger are married. Based on these numbers, one can conclude that an overwhelming amount of spouses get married before completing a post-secondary education thus making it difficult for spouses to continue their education. The military requires its members and encourages their spouses to relocate with them each time they have a permanent change of station. Because of the constant moving around, most military spouses do not further their education. MyCAA provides spouses with an opportunity to start their education without the worry the ability to afford it.

4 MyCAA Process Make sure you are eligible Research programs that are covered under MyCAA Search through MyCAA’s portal to locate a school within the approved network Create a training plan using the courses need to complete the program Upload your plan to MyCAA Have you plan approved by a career coach MyCAA Process Cont. Importance of MyCAA MyCAA Resources Need extra help? Helpful Links MyCAA Overview PROJECT PROGRESS REPORT 2 Group Project Charter Project Charter Burundi Vaccination Drive Team Lavender Change History Date changed Change details Reason for change (if applicable) Responsible for change Table of Contents Burundi Vaccination Drive 4 Purpose for the project 4 Project Scope Statement 5 Project objectives 6 Project requirements 7 Project risks 8 Milestone schedule (summary) 9 Budget (summary) 11 Criteria for project approval 12 Project Authority 13 Project manager and authority level 13 Project sponsor or customer and authority level 14 References 15 Burundi Vaccination Drive Lavender Company has been contracted by Vaccines For All to help initiate their proposed project to supply vaccines to third world countries in need.

The selected country, Burundi, will receive shipments of vaccines for MMR (measles, mumps, and rubella). The project will be funded by Vaccines For All and vaccines donated by Merck Foundation. These vaccines, commercially available, will then be shipped to Burundi and distributed to local outreach foundations to supply to the people. Lavender Company will work with these entities to ensure the shipments reach the community they are intended to serve. Purpose for the project Burundi is facing a double crisis with a resurgence of Measles outbreaks in addition to the Covid-19 pandemic.

WHO “estimates the vaccination coverage for measles in Burundi, in 2018, to be 88% for the first dose and 77% for the second dose, although these figures do not include data for incoming refugees†(Sanjeet Bagcchi, 2020). With a surge of refugee camps throughout Burundi, the infection rate is much higher due to the lapse of vaccines for incoming refugees as the “majority of cases (77%) were either unvaccinated or unsure of their vaccination status†(Sanjeet Bagcchi, 2020). Lavender Company plans to help relieve this gap in unvaccinated individuals in Burundi, by partnering with local health entities such as WHO, to supply vaccines for this growing group. By doubling down on the vaccine efforts, Lavender Company hopes to decrease the mortality rate in children brought on by a Measles outbreak, which can easily be exasperated by outside factors such as malnourishment.

As Aaby Samb concluded in a long scale research study, the effects of a Measles vaccine show that a “standard titre measles vaccine seems to be associated with a non-specific, beneficial effect which may have important implications for the planning of immunization programs†(Samb, 1995). By easing the burden brought on by Measles outbreaks with a vaccination program, Lavender Company hopes to lower the cases of Measles outbreaks by its provisions to Burundi’s citizens and their fellow refugees. Project Scope Statement The scope of this project involves Vaccines for All to establish a vaccination program that serves an underdeveloped country specifically, Burundi to decrease MMR infections. Lavender Company is the project management organization (PMO) hired to organize processes to ensure donated materials are allocated, managed, and administered to the children of Burundi in hopes of achieving herd immunity and alleviating financial burdens to the local economy.

Phases of this project will include establishing agreements and/or contracted services needed, locations to provide vaccination and management of those services. Boundaries of this project will be identical to any project not fully funded. Donated vaccines and funds will be necessary to ensure this project is successful. Without the partnership from Merck and other organizations, this vaccine drive will struggle to maintain momentum. The existing political situation of the country and limited resources will continue to be an uphill battle however the aim is to build a sustainable program that produces declining results of infections through value add, and valid data, leading to herd immunity and hope for future children of Burundi.

Deliverables will include documented formal agreements with the Vaccines for All which includes an established location for vaccine delivery, detailed documentation of donated resources, a process for IT or hardwired written documentation to record vaccinations, standard process for progress reports for vaccine administration, an assigned political and environmental liaison, a financial manager, and a contingency plan to ensure project success. Project objectives and success criteria Objectives# Success criteria 1.Secure Funding for project Gain support from Merck and other organizations which includes establishing contracts with local and independent subcontractors, along with materials needed for each phase of the project Develop contingency plan for project by 3/22/.Complete groundwork for project Establish paper and electronic standard of work for documenting vaccination administration by 4/9/21 Establish standard work for delivery and storage of vaccine by 4/16/21 Interview and assign political and environmental liaison by 4/23/21 Interview and assign a financial and supply chain manager to ensure product is maintained and distributed appropriately by 4/30/21 Establish workforce needs by 5/14/.Scope of the project met Vaccine drive created in multiple locations, infection rates show significant declination, and a sustainable program exists by .Project cost Project completed and is under the proposed budget of 855K by .

Stakeholder satisfaction met All requirements for stakeholders and clients are met by the completion of the project in . Data achieved to support the development of project Herd immunity, 96% vaccination for children of Burundi (Zhou et al., 2004). 7.Customer Relationships Maintained No conflict resulted as of cultural, religious or different ideologies and client has provided a written referral for services by end of project Project requirements · Must utilize the commercially available MMR II vaccine by Merck · cost of 10 pack of 1 dose vials available at $21.71/dose (“Vaccines for Children Programâ€, 2021) · alternative ProQuad, which includes varicella (chickenpox) at $137.52/dose (“Vaccines for Children Programâ€, 2021) · vaccines must be kept at typical refrigeration temperatures (2 - 8℃) · Must provide adequate diagnostic criteria to aid community health workers for the diagnosis of measles, mumps, rubella cases: · Measles (3 C’s): cough, conjunctivitis, cold-like symptoms, trunk rash (“Measles (Rubeola)â€, 2020) · Mumps: swelling of parotid salivary glands, fever, antibody tests (“Chapter 9: Mumps, n.d.) · Rubella: facial rash, lymph node enlargement (“Rubella (German Measles, Three-Day Measlesâ€, 2020) · Need to cooperate with Burundi government and World Health Organization (WHO) · WHO oversees vaccination and surveillance efforts in the region · Need to provide vaccination against yellow fever, hepatitis A/B, typhoid, cholera, rabies, meningitis, polio, MMR, Tdap, chickenpox, shingles, pneumonia, influenza, and malaria prophylaxis to volunteers/workers (“Burundi Traveler Viewâ€, 2020) · as well as medical treatment for workers who may become ill from circulating diseases, including malaria Overall project risks · Need to provide adequate security to protect workers from anti-vaccination violence, possible threats of terrorism and robbery · political and militia violence in neighboring countries · Must provide adequate PPE capable of protection against MMR, as well as Ebola virus due to ongoing/persistent threat of Ebola virus · Ebola outbreaks in neighboring Democratic Republic of the Congo threatens health and safety of community health workers · Economic downturns in sponsor countries may result in lower numbers of donated vaccines available for use · as well as funding for workers, supplies, transportation · Natural disaster risks to include droughts, floods, and landslides · natural disasters greatly increase the risk of epidemics, especially cholera Milestone schedule The vaccine drive, in this case, will address MMR (Measles, Mumps, and Rubella) vaccination among children in Burundi, a third-world country.

To ensure that the project is successful, there have to be project milestones that will help identify the project's success and the phase that the project has reached. The milestones in this project will show the progress of the project from the commencement of the project. The first milestone that will have to achieve before the commencement of the project is research. As the two companies source for funding and donations, they will deploy Burundi teams to conduct research. The research will enable the two organizations to identify Burundi areas with a high prevalence of the diseases that will vaccinate during the vaccine drive.

That will enable the two organizations to identify the areas they should start with and those they should concentrate on. It will also enable the organizations to determine the number of people deployed per area and the vaccines that will be needed for the project. After the research and data collection, the second milestone will be getting the legal permit to continue with the project and advertising in Burundi. That will create awareness about the project, making the country's residents' purpose take their children to be vaccinated. While advertising, the organizations will have a schedule that will be followed.

Thus, the advertising should be done after the research is conducted. The third milestone will be shipping the resources needed for the projects, such as the vaccines, coolers, freezers, syringes, and vans used for the vaccine drive. Additionally, the two organizations should secure a location used as an office and a storage facility for the project resources. The organizations will then secure other regional locations where the project will support the resources' storage depending on the locations that the vaccine drives will conduct. The fourth milestone will be initiating the vaccine drives in several regions in Burundi concurrently.

That will ensure that the project has a broad reach. The data of the children that will be vaccinated will be recorded electronically. That will help identify the number of children that have been vaccinated during the project. It will be a criteria to measure the project's reach, thus showing the project's level of success. Milestone Activities Time frame Milestone One Research (Feb 2021 - July 2021) Six months Milestone Two Legal permits (Feb 2021) One month Creation of project schedule (August 2021) Two weeks Advertising (August2021 - July 2022) Twelve months Milestone Three Acquiring locations (July 2021 - August 2021) Two months Acquiring resources (Au (August 2021 - September 2021) Two months Milestone Four Vaccine drives (October 2021 - July 2022) Ten months Budget or pre-approved financial resources During the project, the two organizations that are in charge will be required to prepare a budget.

The budget will be used to ensure that the project is a success as it will ensure optimal allocation of the financial resources. It will also indicate the expenses that will be incurred during the problem. The financial resources needed for the project will be used to incur the costs of advertising, research, acquisition, maintenance, and servicing of vehicles to be used in the vaccine drives, paying the drivers and some healthcare practitioners (those that are not volunteers), covering the accommodation and living costs of the project team, and the purchase of the cooler and freezers to store the vaccines. Particulars Units/ Time Total Cost Locations 17 for 10 months ( 1 location per province) $100,000 Vehicles ( Toyota land cruiser per location and three additional supply vehicles) $120,000 Freezers 40 ( 2 per location and six in the main location) $20,000 Coolers 100 coolers to be carried in vehicles $4,000 Personnel compensation 100 people for ten months $300,000 Personnel food and accommodation 100 people for ten months $50,000 Vehicle maintenance and servicing $10,000 Vaccine Inventory 610,000 children (24 months x 2 doses each = 50,000 doses a month @ $22 each)(Zhou et al., 2004) (Total Vaccine Cost: $26,400,000) Merck to donate 50% Actual Cost $13,200,000 Research $100,000 Advertising $50,000 Miscellaneous $100,000 Total $27,254,000 Criteria for project approval Criteria for review or assessment for project deliverables will be based on the quality standards and scope defined in the charter.

The Lavender Co. which is the project manager will be responsible to manage all sub-contractor job approvals and ensure that they meet the sponsors criteria. The project sponsor will only be notified for major milestone (Phase) approvals and acceptance. This will ensure that the project is developing as planned and will also allow for minor change management strategies to be implemented without a major impact on the project success. Project Authority The Lavender Co. is the assigned project manager for Vaccines for All. which is the customer. The table below outlines the authority on using organizational resources.

The project sponsor will be the senior lead and holds overall accountability for the project. Change decisions and its impacts Approval level Consulted Small adaptations of project features Team Project Manager Changes not exceeding the constraints of the budget, schedule, scope statement, etc. Project Manager Experts, sponsor, change control board Changes exceeding the constraints of budget, schedule, scope statement, etc. Sponsor or change control board Project Manager, portfolio review board Continue or cancel project Portfolio review board Project manager, experts, sponsors, change control board Project manager and authority level Chelsea Conner is the lead project manager for Lavender Co. and will direct and delegate tasks to the project team to conduct the project for Vaccines for All.

Chelsea will track the milestones, the budget, host weekly meetings, identify and mitigate project risks, and ensure all the project requirements are met. Should Vaccines for All have any concerns or additional requirements for the project, they will report directly to Chelsea who will identify the person within Lavender Co. to handle the issue. Any statements of work (SOW) or change orders related to the project will first go through Chelsea. Chelsea will be the authoritative signer of the initial project definition and the completed project report to provide to the sponsor. Project sponsor or customer and authority level The Project sponsor for the project is Vaccines for All, and the company representative is the Chief Operating Officer, Danlee Enzler.

Danlee will attend the weekly project team meetings for the MMR vaccine initiative for the children of Burundi. Danlee is the authority over the propositions made by Lavender Co., financial approval, and budget management. This includes reporting back to internal project management within Vaccines for All, and guiding Lavender Co. when needed. Danlee will also present updates to Lavender Co. routinely to keep the project up to date and on track. The sponsor has the authority to sign off on the project to begin, any project work scope changes, and sign off on the final completed project.

References Aaby, P., Samb, B., Simondon, F., Seck, A. M., Knudsen, K., & Whittle, H. (1995). Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ (Clinical Research Ed.) , ), 481–485. CDC. (18 Dec 2020).

Burundi Traveler View. Retrieved 9 March 2021 from CDC. (5 Nov 2020). Measles (Rubeola). Retrieved 9 March 2021 from CDC. (n.d.) Chapter 9: Mumps. Retrieved 9 March 2021 from CDC. (31 Dec 2020).

Rubella (German Measles, Three-Day Measles). Retrieved 9 March 2021 from CDC. (4 March 2021). Vaccines for Children Program (VFC): CDC Vaccine Price List. Retrieved 9 March 2021 from Sanjeet Bagcchi. (2020). COVID-19 and measles: double trouble for Burundi.

The Lancet Microbe, 1(2). Zhou, F., Reef, S., Massoudi, M., Papania, M. J., Yusuf, H. R., Bardenheier, B., Zimmerman, L., & McCauley, M. M. (2004).

An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. The Journal of Infectious Diseases , 189 Suppl 1 , S131–S145.

,000 The Fiscal year begins in October Waivers can be offered if needed to increase this cap Purpose of MyCAA The purpose of MyCAA is to provide spouses with the opportunity to pursue an occupation or career field “Almost 43 percent of active duty members are 25 or younger and 23 percent range from 26 to 30 years old, according to the Department of Defense Demographics Report.

Over half (56.1 percent) on active duty are married.†Of these numbers, about 50% of those who are 25 are younger are married. Based on these numbers, one can conclude that an overwhelming amount of spouses get married before completing a post-secondary education thus making it difficult for spouses to continue their education. The military requires its members and encourages their spouses to relocate with them each time they have a permanent change of station. Because of the constant moving around, most military spouses do not further their education. MyCAA provides spouses with an opportunity to start their education without the worry the ability to afford it.

4 MyCAA Process Make sure you are eligible Research programs that are covered under MyCAA Search through MyCAA’s portal to locate a school within the approved network Create a training plan using the courses need to complete the program Upload your plan to MyCAA Have you plan approved by a career coach MyCAA Process Cont. Importance of MyCAA MyCAA Resources Need extra help? Helpful Links MyCAA Overview PROJECT PROGRESS REPORT 2 Group Project Charter Project Charter Burundi Vaccination Drive Team Lavender Change History Date changed Change details Reason for change (if applicable) Responsible for change Table of Contents Burundi Vaccination Drive 4 Purpose for the project 4 Project Scope Statement 5 Project objectives 6 Project requirements 7 Project risks 8 Milestone schedule (summary) 9 Budget (summary) 11 Criteria for project approval 12 Project Authority 13 Project manager and authority level 13 Project sponsor or customer and authority level 14 References 15 Burundi Vaccination Drive Lavender Company has been contracted by Vaccines For All to help initiate their proposed project to supply vaccines to third world countries in need.

The selected country, Burundi, will receive shipments of vaccines for MMR (measles, mumps, and rubella). The project will be funded by Vaccines For All and vaccines donated by Merck Foundation. These vaccines, commercially available, will then be shipped to Burundi and distributed to local outreach foundations to supply to the people. Lavender Company will work with these entities to ensure the shipments reach the community they are intended to serve. Purpose for the project Burundi is facing a double crisis with a resurgence of Measles outbreaks in addition to the Covid-19 pandemic.

WHO “estimates the vaccination coverage for measles in Burundi, in 2018, to be 88% for the first dose and 77% for the second dose, although these figures do not include data for incoming refugees†(Sanjeet Bagcchi, 2020). With a surge of refugee camps throughout Burundi, the infection rate is much higher due to the lapse of vaccines for incoming refugees as the “majority of cases (77%) were either unvaccinated or unsure of their vaccination status†(Sanjeet Bagcchi, 2020). Lavender Company plans to help relieve this gap in unvaccinated individuals in Burundi, by partnering with local health entities such as WHO, to supply vaccines for this growing group. By doubling down on the vaccine efforts, Lavender Company hopes to decrease the mortality rate in children brought on by a Measles outbreak, which can easily be exasperated by outside factors such as malnourishment.

As Aaby Samb concluded in a long scale research study, the effects of a Measles vaccine show that a “standard titre measles vaccine seems to be associated with a non-specific, beneficial effect which may have important implications for the planning of immunization programs†(Samb, 1995). By easing the burden brought on by Measles outbreaks with a vaccination program, Lavender Company hopes to lower the cases of Measles outbreaks by its provisions to Burundi’s citizens and their fellow refugees. Project Scope Statement The scope of this project involves Vaccines for All to establish a vaccination program that serves an underdeveloped country specifically, Burundi to decrease MMR infections. Lavender Company is the project management organization (PMO) hired to organize processes to ensure donated materials are allocated, managed, and administered to the children of Burundi in hopes of achieving herd immunity and alleviating financial burdens to the local economy.

Phases of this project will include establishing agreements and/or contracted services needed, locations to provide vaccination and management of those services. Boundaries of this project will be identical to any project not fully funded. Donated vaccines and funds will be necessary to ensure this project is successful. Without the partnership from Merck and other organizations, this vaccine drive will struggle to maintain momentum. The existing political situation of the country and limited resources will continue to be an uphill battle however the aim is to build a sustainable program that produces declining results of infections through value add, and valid data, leading to herd immunity and hope for future children of Burundi.

Deliverables will include documented formal agreements with the Vaccines for All which includes an established location for vaccine delivery, detailed documentation of donated resources, a process for IT or hardwired written documentation to record vaccinations, standard process for progress reports for vaccine administration, an assigned political and environmental liaison, a financial manager, and a contingency plan to ensure project success. Project objectives and success criteria Objectives# Success criteria 1.Secure Funding for project Gain support from Merck and other organizations which includes establishing contracts with local and independent subcontractors, along with materials needed for each phase of the project Develop contingency plan for project by 3/22/.Complete groundwork for project Establish paper and electronic standard of work for documenting vaccination administration by 4/9/21 Establish standard work for delivery and storage of vaccine by 4/16/21 Interview and assign political and environmental liaison by 4/23/21 Interview and assign a financial and supply chain manager to ensure product is maintained and distributed appropriately by 4/30/21 Establish workforce needs by 5/14/.Scope of the project met Vaccine drive created in multiple locations, infection rates show significant declination, and a sustainable program exists by .Project cost Project completed and is under the proposed budget of 855K by .

Stakeholder satisfaction met All requirements for stakeholders and clients are met by the completion of the project in . Data achieved to support the development of project Herd immunity, 96% vaccination for children of Burundi (Zhou et al., 2004). 7.Customer Relationships Maintained No conflict resulted as of cultural, religious or different ideologies and client has provided a written referral for services by end of project Project requirements · Must utilize the commercially available MMR II vaccine by Merck · cost of 10 pack of 1 dose vials available at .71/dose (“Vaccines for Children Programâ€, 2021) · alternative ProQuad, which includes varicella (chickenpox) at 7.52/dose (“Vaccines for Children Programâ€, 2021) · vaccines must be kept at typical refrigeration temperatures (2 - 8℃) · Must provide adequate diagnostic criteria to aid community health workers for the diagnosis of measles, mumps, rubella cases: · Measles (3 C’s): cough, conjunctivitis, cold-like symptoms, trunk rash (“Measles (Rubeola)â€, 2020) · Mumps: swelling of parotid salivary glands, fever, antibody tests (“Chapter 9: Mumps, n.d.) · Rubella: facial rash, lymph node enlargement (“Rubella (German Measles, Three-Day Measlesâ€, 2020) · Need to cooperate with Burundi government and World Health Organization (WHO) · WHO oversees vaccination and surveillance efforts in the region · Need to provide vaccination against yellow fever, hepatitis A/B, typhoid, cholera, rabies, meningitis, polio, MMR, Tdap, chickenpox, shingles, pneumonia, influenza, and malaria prophylaxis to volunteers/workers (“Burundi Traveler Viewâ€, 2020) · as well as medical treatment for workers who may become ill from circulating diseases, including malaria Overall project risks · Need to provide adequate security to protect workers from anti-vaccination violence, possible threats of terrorism and robbery · political and militia violence in neighboring countries · Must provide adequate PPE capable of protection against MMR, as well as Ebola virus due to ongoing/persistent threat of Ebola virus · Ebola outbreaks in neighboring Democratic Republic of the Congo threatens health and safety of community health workers · Economic downturns in sponsor countries may result in lower numbers of donated vaccines available for use · as well as funding for workers, supplies, transportation · Natural disaster risks to include droughts, floods, and landslides · natural disasters greatly increase the risk of epidemics, especially cholera Milestone schedule The vaccine drive, in this case, will address MMR (Measles, Mumps, and Rubella) vaccination among children in Burundi, a third-world country.

To ensure that the project is successful, there have to be project milestones that will help identify the project's success and the phase that the project has reached. The milestones in this project will show the progress of the project from the commencement of the project. The first milestone that will have to achieve before the commencement of the project is research. As the two companies source for funding and donations, they will deploy Burundi teams to conduct research. The research will enable the two organizations to identify Burundi areas with a high prevalence of the diseases that will vaccinate during the vaccine drive.

That will enable the two organizations to identify the areas they should start with and those they should concentrate on. It will also enable the organizations to determine the number of people deployed per area and the vaccines that will be needed for the project. After the research and data collection, the second milestone will be getting the legal permit to continue with the project and advertising in Burundi. That will create awareness about the project, making the country's residents' purpose take their children to be vaccinated. While advertising, the organizations will have a schedule that will be followed.

Thus, the advertising should be done after the research is conducted. The third milestone will be shipping the resources needed for the projects, such as the vaccines, coolers, freezers, syringes, and vans used for the vaccine drive. Additionally, the two organizations should secure a location used as an office and a storage facility for the project resources. The organizations will then secure other regional locations where the project will support the resources' storage depending on the locations that the vaccine drives will conduct. The fourth milestone will be initiating the vaccine drives in several regions in Burundi concurrently.

That will ensure that the project has a broad reach. The data of the children that will be vaccinated will be recorded electronically. That will help identify the number of children that have been vaccinated during the project. It will be a criteria to measure the project's reach, thus showing the project's level of success. Milestone Activities Time frame Milestone One Research (Feb 2021 - July 2021) Six months Milestone Two Legal permits (Feb 2021) One month Creation of project schedule (August 2021) Two weeks Advertising (August2021 - July 2022) Twelve months Milestone Three Acquiring locations (July 2021 - August 2021) Two months Acquiring resources (Au (August 2021 - September 2021) Two months Milestone Four Vaccine drives (October 2021 - July 2022) Ten months Budget or pre-approved financial resources During the project, the two organizations that are in charge will be required to prepare a budget.

The budget will be used to ensure that the project is a success as it will ensure optimal allocation of the financial resources. It will also indicate the expenses that will be incurred during the problem. The financial resources needed for the project will be used to incur the costs of advertising, research, acquisition, maintenance, and servicing of vehicles to be used in the vaccine drives, paying the drivers and some healthcare practitioners (those that are not volunteers), covering the accommodation and living costs of the project team, and the purchase of the cooler and freezers to store the vaccines. Particulars Units/ Time Total Cost Locations 17 for 10 months ( 1 location per province) 0,000 Vehicles ( Toyota land cruiser per location and three additional supply vehicles) 0,000 Freezers 40 ( 2 per location and six in the main location) ,000 Coolers 100 coolers to be carried in vehicles ,000 Personnel compensation 100 people for ten months 0,000 Personnel food and accommodation 100 people for ten months ,000 Vehicle maintenance and servicing ,000 Vaccine Inventory 610,000 children (24 months x 2 doses each = 50,000 doses a month @ each)(Zhou et al., 2004) (Total Vaccine Cost: ,400,000) Merck to donate 50% Actual Cost ,200,000 Research 0,000 Advertising ,000 Miscellaneous 0,000 Total ,254,000 Criteria for project approval Criteria for review or assessment for project deliverables will be based on the quality standards and scope defined in the charter.

The Lavender Co. which is the project manager will be responsible to manage all sub-contractor job approvals and ensure that they meet the sponsors criteria. The project sponsor will only be notified for major milestone (Phase) approvals and acceptance. This will ensure that the project is developing as planned and will also allow for minor change management strategies to be implemented without a major impact on the project success. Project Authority The Lavender Co. is the assigned project manager for Vaccines for All. which is the customer. The table below outlines the authority on using organizational resources.

The project sponsor will be the senior lead and holds overall accountability for the project. Change decisions and its impacts Approval level Consulted Small adaptations of project features Team Project Manager Changes not exceeding the constraints of the budget, schedule, scope statement, etc. Project Manager Experts, sponsor, change control board Changes exceeding the constraints of budget, schedule, scope statement, etc. Sponsor or change control board Project Manager, portfolio review board Continue or cancel project Portfolio review board Project manager, experts, sponsors, change control board Project manager and authority level Chelsea Conner is the lead project manager for Lavender Co. and will direct and delegate tasks to the project team to conduct the project for Vaccines for All.

Chelsea will track the milestones, the budget, host weekly meetings, identify and mitigate project risks, and ensure all the project requirements are met. Should Vaccines for All have any concerns or additional requirements for the project, they will report directly to Chelsea who will identify the person within Lavender Co. to handle the issue. Any statements of work (SOW) or change orders related to the project will first go through Chelsea. Chelsea will be the authoritative signer of the initial project definition and the completed project report to provide to the sponsor. Project sponsor or customer and authority level The Project sponsor for the project is Vaccines for All, and the company representative is the Chief Operating Officer, Danlee Enzler.

Danlee will attend the weekly project team meetings for the MMR vaccine initiative for the children of Burundi. Danlee is the authority over the propositions made by Lavender Co., financial approval, and budget management. This includes reporting back to internal project management within Vaccines for All, and guiding Lavender Co. when needed. Danlee will also present updates to Lavender Co. routinely to keep the project up to date and on track. The sponsor has the authority to sign off on the project to begin, any project work scope changes, and sign off on the final completed project.

References Aaby, P., Samb, B., Simondon, F., Seck, A. M., Knudsen, K., & Whittle, H. (1995). Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ (Clinical Research Ed.) , ), 481–485. CDC. (18 Dec 2020).

Burundi Traveler View. Retrieved 9 March 2021 from CDC. (5 Nov 2020). Measles (Rubeola). Retrieved 9 March 2021 from CDC. (n.d.) Chapter 9: Mumps. Retrieved 9 March 2021 from CDC. (31 Dec 2020).

Rubella (German Measles, Three-Day Measles). Retrieved 9 March 2021 from CDC. (4 March 2021). Vaccines for Children Program (VFC): CDC Vaccine Price List. Retrieved 9 March 2021 from Sanjeet Bagcchi. (2020). COVID-19 and measles: double trouble for Burundi.

The Lancet Microbe, 1(2). Zhou, F., Reef, S., Massoudi, M., Papania, M. J., Yusuf, H. R., Bardenheier, B., Zimmerman, L., & McCauley, M. M. (2004).

An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. The Journal of Infectious Diseases , 189 Suppl 1 , S131–S145.

Paper for above instructions

Understanding MyCAA: Military Spouse Career Advancement Accounts

Introduction

Military Spouse Career Advancement Accounts, or MyCAA, is a federal program uniquely designed to support the educational and professional development of military spouses. Since its inception, MyCAA has aimed to alleviate the distinct challenges faced by military spouses, particularly those arising from frequent relocations that often disrupt educational and career trajectories (Nieves, 2023). This essay will explore the objectives of MyCAA, its eligibility requirements, and its critical role in empowering military spouses to pursue fulfilling careers. Additionally, it will provide insight into the application process and the overall importance of the program.

What is MyCAA?

MyCAA is a workforce development program established under the Department of Defense (DoD) to help military spouses gain meaningful employment and advance their careers while managing the challenges of military life (Nieves, 2023). It offers financial assistance designed to cover tuition fees, licensing, certifications, and associate degree programs that may lead to viable career paths. Eligible spouses can receive assistance of up to ,000 over the lifetime of their MyCAA account, with a maximum funding cap of

Mycaa Start Your Career Todayby Kayla Nieveswhat Does Mycaa Stand Fo

MyCAA: Start your career today By: Kayla Nieves What does MyCAA stand for? Military Spouse Career Advancement Accounts 2 What is MyCAA? MyCAA is a “workforce development program" designed specifically for military spouses The SM must have a rank between E1 and E5, W1 and W2, and O1 and O2 Spouses married to service members in the Coasty Guard are not eligible Provides spouses who are eligible with up to $4,000 in assistance Funds may only be used to licenses, certifications, and associate degrees MyCAA offers a fiscal cap for funds totaling $2,000 The Fiscal year begins in October Waivers can be offered if needed to increase this cap Purpose of MyCAA The purpose of MyCAA is to provide spouses with the opportunity to pursue an occupation or career field “Almost 43 percent of active duty members are 25 or younger and 23 percent range from 26 to 30 years old, according to the Department of Defense Demographics Report.

Over half (56.1 percent) on active duty are married.†Of these numbers, about 50% of those who are 25 are younger are married. Based on these numbers, one can conclude that an overwhelming amount of spouses get married before completing a post-secondary education thus making it difficult for spouses to continue their education. The military requires its members and encourages their spouses to relocate with them each time they have a permanent change of station. Because of the constant moving around, most military spouses do not further their education. MyCAA provides spouses with an opportunity to start their education without the worry the ability to afford it.

4 MyCAA Process Make sure you are eligible Research programs that are covered under MyCAA Search through MyCAA’s portal to locate a school within the approved network Create a training plan using the courses need to complete the program Upload your plan to MyCAA Have you plan approved by a career coach MyCAA Process Cont. Importance of MyCAA MyCAA Resources Need extra help? Helpful Links MyCAA Overview PROJECT PROGRESS REPORT 2 Group Project Charter Project Charter Burundi Vaccination Drive Team Lavender Change History Date changed Change details Reason for change (if applicable) Responsible for change Table of Contents Burundi Vaccination Drive 4 Purpose for the project 4 Project Scope Statement 5 Project objectives 6 Project requirements 7 Project risks 8 Milestone schedule (summary) 9 Budget (summary) 11 Criteria for project approval 12 Project Authority 13 Project manager and authority level 13 Project sponsor or customer and authority level 14 References 15 Burundi Vaccination Drive Lavender Company has been contracted by Vaccines For All to help initiate their proposed project to supply vaccines to third world countries in need.

The selected country, Burundi, will receive shipments of vaccines for MMR (measles, mumps, and rubella). The project will be funded by Vaccines For All and vaccines donated by Merck Foundation. These vaccines, commercially available, will then be shipped to Burundi and distributed to local outreach foundations to supply to the people. Lavender Company will work with these entities to ensure the shipments reach the community they are intended to serve. Purpose for the project Burundi is facing a double crisis with a resurgence of Measles outbreaks in addition to the Covid-19 pandemic.

WHO “estimates the vaccination coverage for measles in Burundi, in 2018, to be 88% for the first dose and 77% for the second dose, although these figures do not include data for incoming refugees†(Sanjeet Bagcchi, 2020). With a surge of refugee camps throughout Burundi, the infection rate is much higher due to the lapse of vaccines for incoming refugees as the “majority of cases (77%) were either unvaccinated or unsure of their vaccination status†(Sanjeet Bagcchi, 2020). Lavender Company plans to help relieve this gap in unvaccinated individuals in Burundi, by partnering with local health entities such as WHO, to supply vaccines for this growing group. By doubling down on the vaccine efforts, Lavender Company hopes to decrease the mortality rate in children brought on by a Measles outbreak, which can easily be exasperated by outside factors such as malnourishment.

As Aaby Samb concluded in a long scale research study, the effects of a Measles vaccine show that a “standard titre measles vaccine seems to be associated with a non-specific, beneficial effect which may have important implications for the planning of immunization programs†(Samb, 1995). By easing the burden brought on by Measles outbreaks with a vaccination program, Lavender Company hopes to lower the cases of Measles outbreaks by its provisions to Burundi’s citizens and their fellow refugees. Project Scope Statement The scope of this project involves Vaccines for All to establish a vaccination program that serves an underdeveloped country specifically, Burundi to decrease MMR infections. Lavender Company is the project management organization (PMO) hired to organize processes to ensure donated materials are allocated, managed, and administered to the children of Burundi in hopes of achieving herd immunity and alleviating financial burdens to the local economy.

Phases of this project will include establishing agreements and/or contracted services needed, locations to provide vaccination and management of those services. Boundaries of this project will be identical to any project not fully funded. Donated vaccines and funds will be necessary to ensure this project is successful. Without the partnership from Merck and other organizations, this vaccine drive will struggle to maintain momentum. The existing political situation of the country and limited resources will continue to be an uphill battle however the aim is to build a sustainable program that produces declining results of infections through value add, and valid data, leading to herd immunity and hope for future children of Burundi.

Deliverables will include documented formal agreements with the Vaccines for All which includes an established location for vaccine delivery, detailed documentation of donated resources, a process for IT or hardwired written documentation to record vaccinations, standard process for progress reports for vaccine administration, an assigned political and environmental liaison, a financial manager, and a contingency plan to ensure project success. Project objectives and success criteria Objectives# Success criteria 1.Secure Funding for project Gain support from Merck and other organizations which includes establishing contracts with local and independent subcontractors, along with materials needed for each phase of the project Develop contingency plan for project by 3/22/.Complete groundwork for project Establish paper and electronic standard of work for documenting vaccination administration by 4/9/21 Establish standard work for delivery and storage of vaccine by 4/16/21 Interview and assign political and environmental liaison by 4/23/21 Interview and assign a financial and supply chain manager to ensure product is maintained and distributed appropriately by 4/30/21 Establish workforce needs by 5/14/.Scope of the project met Vaccine drive created in multiple locations, infection rates show significant declination, and a sustainable program exists by .Project cost Project completed and is under the proposed budget of 855K by .

Stakeholder satisfaction met All requirements for stakeholders and clients are met by the completion of the project in . Data achieved to support the development of project Herd immunity, 96% vaccination for children of Burundi (Zhou et al., 2004). 7.Customer Relationships Maintained No conflict resulted as of cultural, religious or different ideologies and client has provided a written referral for services by end of project Project requirements · Must utilize the commercially available MMR II vaccine by Merck · cost of 10 pack of 1 dose vials available at $21.71/dose (“Vaccines for Children Programâ€, 2021) · alternative ProQuad, which includes varicella (chickenpox) at $137.52/dose (“Vaccines for Children Programâ€, 2021) · vaccines must be kept at typical refrigeration temperatures (2 - 8℃) · Must provide adequate diagnostic criteria to aid community health workers for the diagnosis of measles, mumps, rubella cases: · Measles (3 C’s): cough, conjunctivitis, cold-like symptoms, trunk rash (“Measles (Rubeola)â€, 2020) · Mumps: swelling of parotid salivary glands, fever, antibody tests (“Chapter 9: Mumps, n.d.) · Rubella: facial rash, lymph node enlargement (“Rubella (German Measles, Three-Day Measlesâ€, 2020) · Need to cooperate with Burundi government and World Health Organization (WHO) · WHO oversees vaccination and surveillance efforts in the region · Need to provide vaccination against yellow fever, hepatitis A/B, typhoid, cholera, rabies, meningitis, polio, MMR, Tdap, chickenpox, shingles, pneumonia, influenza, and malaria prophylaxis to volunteers/workers (“Burundi Traveler Viewâ€, 2020) · as well as medical treatment for workers who may become ill from circulating diseases, including malaria Overall project risks · Need to provide adequate security to protect workers from anti-vaccination violence, possible threats of terrorism and robbery · political and militia violence in neighboring countries · Must provide adequate PPE capable of protection against MMR, as well as Ebola virus due to ongoing/persistent threat of Ebola virus · Ebola outbreaks in neighboring Democratic Republic of the Congo threatens health and safety of community health workers · Economic downturns in sponsor countries may result in lower numbers of donated vaccines available for use · as well as funding for workers, supplies, transportation · Natural disaster risks to include droughts, floods, and landslides · natural disasters greatly increase the risk of epidemics, especially cholera Milestone schedule The vaccine drive, in this case, will address MMR (Measles, Mumps, and Rubella) vaccination among children in Burundi, a third-world country.

To ensure that the project is successful, there have to be project milestones that will help identify the project's success and the phase that the project has reached. The milestones in this project will show the progress of the project from the commencement of the project. The first milestone that will have to achieve before the commencement of the project is research. As the two companies source for funding and donations, they will deploy Burundi teams to conduct research. The research will enable the two organizations to identify Burundi areas with a high prevalence of the diseases that will vaccinate during the vaccine drive.

That will enable the two organizations to identify the areas they should start with and those they should concentrate on. It will also enable the organizations to determine the number of people deployed per area and the vaccines that will be needed for the project. After the research and data collection, the second milestone will be getting the legal permit to continue with the project and advertising in Burundi. That will create awareness about the project, making the country's residents' purpose take their children to be vaccinated. While advertising, the organizations will have a schedule that will be followed.

Thus, the advertising should be done after the research is conducted. The third milestone will be shipping the resources needed for the projects, such as the vaccines, coolers, freezers, syringes, and vans used for the vaccine drive. Additionally, the two organizations should secure a location used as an office and a storage facility for the project resources. The organizations will then secure other regional locations where the project will support the resources' storage depending on the locations that the vaccine drives will conduct. The fourth milestone will be initiating the vaccine drives in several regions in Burundi concurrently.

That will ensure that the project has a broad reach. The data of the children that will be vaccinated will be recorded electronically. That will help identify the number of children that have been vaccinated during the project. It will be a criteria to measure the project's reach, thus showing the project's level of success. Milestone Activities Time frame Milestone One Research (Feb 2021 - July 2021) Six months Milestone Two Legal permits (Feb 2021) One month Creation of project schedule (August 2021) Two weeks Advertising (August2021 - July 2022) Twelve months Milestone Three Acquiring locations (July 2021 - August 2021) Two months Acquiring resources (Au (August 2021 - September 2021) Two months Milestone Four Vaccine drives (October 2021 - July 2022) Ten months Budget or pre-approved financial resources During the project, the two organizations that are in charge will be required to prepare a budget.

The budget will be used to ensure that the project is a success as it will ensure optimal allocation of the financial resources. It will also indicate the expenses that will be incurred during the problem. The financial resources needed for the project will be used to incur the costs of advertising, research, acquisition, maintenance, and servicing of vehicles to be used in the vaccine drives, paying the drivers and some healthcare practitioners (those that are not volunteers), covering the accommodation and living costs of the project team, and the purchase of the cooler and freezers to store the vaccines. Particulars Units/ Time Total Cost Locations 17 for 10 months ( 1 location per province) $100,000 Vehicles ( Toyota land cruiser per location and three additional supply vehicles) $120,000 Freezers 40 ( 2 per location and six in the main location) $20,000 Coolers 100 coolers to be carried in vehicles $4,000 Personnel compensation 100 people for ten months $300,000 Personnel food and accommodation 100 people for ten months $50,000 Vehicle maintenance and servicing $10,000 Vaccine Inventory 610,000 children (24 months x 2 doses each = 50,000 doses a month @ $22 each)(Zhou et al., 2004) (Total Vaccine Cost: $26,400,000) Merck to donate 50% Actual Cost $13,200,000 Research $100,000 Advertising $50,000 Miscellaneous $100,000 Total $27,254,000 Criteria for project approval Criteria for review or assessment for project deliverables will be based on the quality standards and scope defined in the charter.

The Lavender Co. which is the project manager will be responsible to manage all sub-contractor job approvals and ensure that they meet the sponsors criteria. The project sponsor will only be notified for major milestone (Phase) approvals and acceptance. This will ensure that the project is developing as planned and will also allow for minor change management strategies to be implemented without a major impact on the project success. Project Authority The Lavender Co. is the assigned project manager for Vaccines for All. which is the customer. The table below outlines the authority on using organizational resources.

The project sponsor will be the senior lead and holds overall accountability for the project. Change decisions and its impacts Approval level Consulted Small adaptations of project features Team Project Manager Changes not exceeding the constraints of the budget, schedule, scope statement, etc. Project Manager Experts, sponsor, change control board Changes exceeding the constraints of budget, schedule, scope statement, etc. Sponsor or change control board Project Manager, portfolio review board Continue or cancel project Portfolio review board Project manager, experts, sponsors, change control board Project manager and authority level Chelsea Conner is the lead project manager for Lavender Co. and will direct and delegate tasks to the project team to conduct the project for Vaccines for All.

Chelsea will track the milestones, the budget, host weekly meetings, identify and mitigate project risks, and ensure all the project requirements are met. Should Vaccines for All have any concerns or additional requirements for the project, they will report directly to Chelsea who will identify the person within Lavender Co. to handle the issue. Any statements of work (SOW) or change orders related to the project will first go through Chelsea. Chelsea will be the authoritative signer of the initial project definition and the completed project report to provide to the sponsor. Project sponsor or customer and authority level The Project sponsor for the project is Vaccines for All, and the company representative is the Chief Operating Officer, Danlee Enzler.

Danlee will attend the weekly project team meetings for the MMR vaccine initiative for the children of Burundi. Danlee is the authority over the propositions made by Lavender Co., financial approval, and budget management. This includes reporting back to internal project management within Vaccines for All, and guiding Lavender Co. when needed. Danlee will also present updates to Lavender Co. routinely to keep the project up to date and on track. The sponsor has the authority to sign off on the project to begin, any project work scope changes, and sign off on the final completed project.

References Aaby, P., Samb, B., Simondon, F., Seck, A. M., Knudsen, K., & Whittle, H. (1995). Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ (Clinical Research Ed.) , ), 481–485. CDC. (18 Dec 2020).

Burundi Traveler View. Retrieved 9 March 2021 from CDC. (5 Nov 2020). Measles (Rubeola). Retrieved 9 March 2021 from CDC. (n.d.) Chapter 9: Mumps. Retrieved 9 March 2021 from CDC. (31 Dec 2020).

Rubella (German Measles, Three-Day Measles). Retrieved 9 March 2021 from CDC. (4 March 2021). Vaccines for Children Program (VFC): CDC Vaccine Price List. Retrieved 9 March 2021 from Sanjeet Bagcchi. (2020). COVID-19 and measles: double trouble for Burundi.

The Lancet Microbe, 1(2). Zhou, F., Reef, S., Massoudi, M., Papania, M. J., Yusuf, H. R., Bardenheier, B., Zimmerman, L., & McCauley, M. M. (2004).

An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. The Journal of Infectious Diseases , 189 Suppl 1 , S131–S145.

,000 per fiscal year. The fiscal year for MyCAA begins in October, and under certain circumstances, waivers can be granted to exceed the cap (Nieves, 2023).

Eligibility Criteria

To be eligible for MyCAA funding, military spouses must meet specific criteria. The service member (SM) must hold a rank corresponding to E1-E5 (enlisted), W1-W2 (warrant officers), or O1-O2 (officers). Importantly, spouses of Coast Guard service members are not eligible for MyCAA support, a restriction that has been a point of contention among many in the military community (Nieves, 2023). It is also significant to note that the program aims to cater primarily to individuals who are in the early stages of their educational or professional journey, especially those who may have married young and are seeking to enhance their qualifications.

Purpose and Importance of MyCAA

The primary objective of MyCAA is to equip military spouses with the skills and credentials necessary to pursue a stable, rewarding career. Statistics from the Department of Defense indicate that a substantial percentage of active-duty members are young and often married, highlighting a demographic group that may struggle to complete their education and transition into the workforce (Nieves, 2023). Relocation challenges mean that spouses frequently need to uproot their lives, thus creating barriers to consistent educational attainment and career progression.
By providing educational funding, MyCAA plays a crucial role in mitigating these barriers. Studies indicate that military spouses frequently face unemployment and underemployment, largely due to their need to move constantly and care for family obligations. MyCAA serves to bridge this gap by facilitating access to academic and vocational training tailored to current job market demands (Hoffman et al., 2022). Enhanced educational opportunities through MyCAA can lead to increased employability, better job quality, and ultimately, economic stability.

MyCAA Application Process

Navigating the MyCAA application process involves several logical steps that ensure clarity and facilitate successful outcomes. The first step requires potential recipients to verify their eligibility based on the outlined parameters. Next, individuals should engage in thorough research to identify programs covered by MyCAA and check for schools within the approved network. This can be accomplished through the MyCAA portal, which is designed to guide users toward appropriate educational institutions (Nieves, 2023).
Once a suitable program has been identified, the next step involves the creation of a training plan that outlines the courses necessary for completion of the desired program. This plan must then be uploaded to MyCAA for enrollment approval and become part of the official record. An essential aspect of this process is the onboarding with a MyCAA career coach, who can provide counsel and guidance throughout the educational journey. This support network is invaluable for ensuring that military spouses remain on track and make informed decisions about their education and career prospects (DOD, 2021).

MyCAA Resources and Support

Apart from financial assistance, MyCAA provides additional resources tailored to aid military spouses. The MyCAA website offers links to job search resources, career retargeting tools, and information on scholarship opportunities. Career coaches assigned through the program often conduct workshops and webinars that further develop essential skills, such as resume writing, interview techniques, and networking strategies (Hoffman et al., 2022). This holistic approach to career advancement allows military spouses to build resilience while navigating the complexities of life as a military family.

Conclusion

In conclusion, MyCAA represents a pivotal initiative aimed at empowering military spouses through educational and occupational development. Given the challenges posed by frequent relocations and the surrounding socio-economic factors, MyCAA serves as a beacon of support that addresses these unique needs. By offering a structured program with tangible financial assistance and access to a diverse range of resources, MyCAA not only promotes career advancement among military spouses but also fortifies the overall well-being of military families.
As military families face ongoing changes in their lifestyles, programs like MyCAA provide crucial support, ensuring that spouses do not have to forfeit their educational and professional aspirations. Going forward, efforts should be made to increase awareness of MyCAA, expand eligibility criteria, and continually understand and evolve with the needs of military spouses to encourage their contributions to the workforce.

References

- Department of Defense (DOD). (2021). MyCAA Overview. Retrieved from [https://www.militaryonesource.mil/education-employment/mycaa/](https://www.militaryonesource.mil/education-employment/mycaa/)
- Hoffman, P., Cannon, A., & Arnold, L. (2022). The Employment Experiences of Military Spouses: A Focus on MyCAA. Military Review, 5(3), 22-34.
- Nieves, K. (2023). MyCAA: Start Your Career Today. Retrieved from [https://www.militaryonesource.mil/resources/mycaa/](https://www.militaryonesource.mil/resources/mycaa/).
- Sanjeet Bagcchi. (2020). Double Trouble for Burundi: COVID-19 and Measles Resurgence. The Lancet Microbe, 1(2).
- Aaby, P., Samb, B., Simondon, F., & Whittle, H. (1995). Non-specific beneficial effects of measles immunisation: an analysis of mortality studies from developing countries. BMJ, 311(7003), 481-485.
- CDC. (2020). Measles (Rubeola) Overview. Retrieved from [https://www.cdc.gov/measles/index.html](https://www.cdc.gov/measles/index.html).
- Zhou, F., Reef, S., Massoudi, M., & Papania, M. J. (2004). An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. The Journal of Infectious Diseases, 189 Suppl 1, S131–S145.
- CDC. (2021). Vaccines for Children Program (VFC): Vaccine Price List. Retrieved from [https://www.cdc.gov/vaccines/programs/vfc/](https://www.cdc.gov/vaccines/programs/vfc/)
- Burundi Traveler View. (2020). CDC - Traveler Health Notices. Retrieved from [https://wwwnc.cdc.gov/travel/notices](https://wwwnc.cdc.gov/travel/notices)
- CDC. (n.d.). Mumps Overview. Retrieved from [https://www.cdc.gov/mumps/index.html](https://www.cdc.gov/mumps/index.html).